Ubs Group Ag Aridis Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.31 - $1.5 $1,545 - $7,477	-4,985 Reduced 65.01%	2,683 $0
Q4 2022 Feb 08, 2023	BUY	$0.81 - $1.18 $3,621 - $5,275	4,471 Added 139.85%	7,668 $9,000
Q3 2022 Nov 10, 2022	SELL	$0.73 - $2.47 $3,720 - $12,587	-5,096 Reduced 61.45%	3,197 $3,000
Q2 2022 Aug 10, 2022	BUY	$0.91 - $1.7 $7,546 - $14,098	8,293 New	8,293 $9,000
Q3 2021 Nov 15, 2021	SELL	$3.55 - $7.49 $11,462 - $24,185	-3,229 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$5.3 - $7.4 $17,113 - $23,894	3,229 New	3,229 $24,000
Q1 2021 May 12, 2021	SELL	$5.54 - $8.1 $2,515 - $3,677	-454 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$6.07 - $8.01 $795 - $1,049	-131 Reduced 22.39%	454 $3,000
Q3 2020 Nov 12, 2020	SELL	$6.33 - $7.75 $4,836 - $5,921	-764 Reduced 56.63%	585 $4,000
Q2 2020 Jul 31, 2020	BUY	$5.24 - $8.97 $7,068 - $12,100	1,349 New	1,349 $9,000
Q1 2020 May 01, 2020	SELL	$4.34 - $8.3 $3,185 - $6,092	-734 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$4.16 - $7.1 $1,210 - $2,066	-291 Reduced 28.39%	734 $3,000
Q3 2019 Nov 14, 2019	SELL	$6.57 - $12.2 $6,819 - $12,663	-1,038 Reduced 50.32%	1,025 $7,000
Q2 2019 Aug 14, 2019	BUY	$7.1 - $11.34 $2,925 - $4,672	412 Added 24.95%	2,063 $21,000
Q1 2019 May 14, 2019	SELL	$8.15 - $11.59 $3,056 - $4,346	-375 Reduced 18.51%	1,651 $19,000
Q4 2018 Feb 14, 2019	BUY	$7.82 - $13.03 $1,696 - $2,827	217 Added 12.0%	2,026 $22,000
Q3 2018 Nov 14, 2018	BUY	$11.92 - $13.69 $21,563 - $24,765	1,809 New	1,809 $24,000

50.2K

Ticker ARDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,701,600
Description
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.